$1 Billion is the total value of ARMISTICE CAPITAL, LLC's 67 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PZZA | New | PAPA JOHNS INTL INCcall | $25,250,000 | – | 450,000 | +100.0% | 2.52% | – |
| POST | New | POST HLDGS INC | $24,720,000 | – | 312,000 | +100.0% | 2.46% | – |
| CMG | New | CHIPOTLE MEXICAN GRILL INC | $22,544,000 | – | 78,000 | +100.0% | 2.25% | – |
| UAA | New | UNDER ARMOUR INCcl a | $20,202,000 | – | 1,400,000 | +100.0% | 2.01% | – |
| HOG | New | HARLEY DAVIDSON INC | $19,538,000 | – | 384,000 | +100.0% | 1.95% | – |
| KORS | New | MICHAEL KORS HLDGS LTD | $14,856,000 | – | 236,000 | +100.0% | 1.48% | – |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $14,614,000 | – | 412,000 | +100.0% | 1.46% | – |
| CVS | New | CVS HEALTH CORP | $14,500,000 | – | 200,000 | +100.0% | 1.45% | – |
| GME | New | GAMESTOP CORP NEWcl a | $14,360,000 | – | 800,000 | +100.0% | 1.43% | – |
| GPS | New | GAP INC DEL | $13,624,000 | – | 400,000 | +100.0% | 1.36% | – |
| AET | New | AETNA INC NEW | $11,545,000 | – | 64,000 | +100.0% | 1.15% | – |
| EBAY | New | EBAY INC | $9,963,000 | – | 264,000 | +100.0% | 0.99% | – |
| SHPG | New | SHIRE PLCsponsored adr | $9,928,000 | – | 64,000 | +100.0% | 0.99% | – |
| PZZA | New | PAPA JOHNS INTL INC | $9,651,000 | – | 172,000 | +100.0% | 0.96% | – |
| New | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $9,175,000 | – | 21,760,000 | +100.0% | 0.92% | – | |
| TPR | New | TAPESTRY INC | $9,023,000 | – | 204,000 | +100.0% | 0.90% | – |
| BBBY | New | BED BATH & BEYOND INC | $6,597,000 | – | 300,000 | +100.0% | 0.66% | – |
| AMZN | New | AMAZON COM INC | $5,847,000 | – | 5,000 | +100.0% | 0.58% | – |
| DKS | New | DICKS SPORTING GOODS INCcall | $5,748,000 | – | 200,000 | +100.0% | 0.57% | – |
| W | New | WAYFAIR INCcl a | $5,458,000 | – | 68,000 | +100.0% | 0.54% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $5,357,000 | – | 384,000 | +100.0% | 0.53% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $5,068,000 | – | 112,000 | +100.0% | 0.50% | – |
| APRN | New | BLUE APRON HLDGS INCcl a | $4,030,000 | – | 1,000,000 | +100.0% | 0.40% | – |
| VICL | New | VICAL INC | $3,660,000 | – | 2,000,000 | +100.0% | 0.36% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $1,674,000 | – | 600,000 | +100.0% | 0.17% | – |
| IPCI | New | INTELLIPHARMACEUTICS INTL IN | $1,549,000 | – | 1,936,000 | +100.0% | 0.15% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $1,269,000 | – | 768,915 | +100.0% | 0.13% | – |
| AYTU | New | AYTU BIOSCIENCE INC | $818,000 | – | 366,667 | +100.0% | 0.08% | – |
| CHEK | New | CHECK CAP LTD | $651,000 | – | 748,000 | +100.0% | 0.06% | – |
| FCSC | New | FIBROCELL SCIENCE INC | $393,000 | – | 613,896 | +100.0% | 0.04% | – |
| BPMX | New | BIOPHARMX CORP | $382,000 | – | 3,470,000 | +100.0% | 0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.